10.70
0.00
(0.00%)
As of 8:08:40 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
750
750
2,090
9,979
8,341
Operating Expense
146,951
146,951
199,896
160,263
127,872
Operating Income
-146,201
-146,201
-197,806
-150,284
-119,531
Net Non Operating Interest Income Expense
2,524
2,524
1,846
-4,500
-1,763
Pretax Income
-36,103
-36,103
-92,783
-58,953
18,969
Tax Provision
30,525
30,525
-55,719
3,756
14,401
Net Income Common Stockholders
-65,697
-65,697
-50,354
-60,558
5,985
Diluted NI Available to Com Stockholders
-65,697
-65,697
-50,354
-60,558
5,985
Basic EPS
-2.40
-2.40
-1.80
-2.10
0.20
Diluted EPS
-2.40
-2.40
-1.80
-2.10
0.20
Basic Average Shares
27,630.25
27,630.25
28,475.94
28,659.10
28,560.37
Diluted Average Shares
27,630.25
27,630.25
28,475.94
28,659.10
29,285.59
Total Operating Income as Reported
-146,199
-146,199
-197,807
-150,282
-119,531
Total Expenses
146,951
146,951
199,896
160,263
127,872
Net Income from Continuing & Discontinued Operation
-65,697
-65,697
-50,354
-60,558
5,985
Normalized Income
-156,254.70
-156,254.70
-147,350.99
-183,195.81
-120,558.31
Interest Income
16,012
16,012
5,799
214
1,183
Interest Expense
13,488
13,488
3,953
4,714
2,946
Net Interest Income
2,524
2,524
1,846
-4,500
-1,763
EBIT
-22,615
-22,615
-88,830
-54,239
21,915
EBITDA
-17,681
-17,681
-79,937
-46,952
28,560
Reconciled Depreciation
4,933
4,933
8,893
7,287
6,645
Net Income from Continuing Operation Net Minority Interest
-65,697
-65,697
-50,354
-60,558
5,985
Total Unusual Items Excluding Goodwill
114,630
114,630
122,781
167,997
173,347
Total Unusual Items
114,630
114,630
122,781
167,997
173,347
Normalized EBITDA
-132,311
-132,311
-202,718
-214,949
-144,787
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
24,072.30
24,072.30
25,784.01
45,359.19
46,803.69
12/31/2020 - 1/7/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CGON CG Oncology, Inc.
18.47
+4.76%
NAMS NewAmsterdam Pharma Company N.V.
14.97
+0.44%
STOK Stoke Therapeutics, Inc.
6.99
+7.21%
ASND Ascendis Pharma A/S
149.95
+4.62%
SRRK Scholar Rock Holding Corporation
27.50
+4.52%
TERN Terns Pharmaceuticals, Inc.
2.1400
0.00%
ARVN Arvinas, Inc.
6.92
+4.53%
SWTX SpringWorks Therapeutics, Inc.
35.40
+2.82%
APLS Apellis Pharmaceuticals, Inc.
19.03
+1.25%
CAPR Capricor Therapeutics, Inc.
9.32
+4.96%